The science of manipulating fluids at the microscale, enabling lab-on-chip devices, organ-on-chip systems, single-cell analysis, and point-of-care diagnostics
Microfluidics is the science and technology of manipulating and controlling fluids at the microscale, typically in channels with dimensions ranging from 10 to 500 micrometers. At this scale, physical phenomena like laminar flow, surface tension, and diffusion dominate over turbulence and gravity, enabling unprecedented control over chemical reactions, cell handling, and molecular analysis.
The term "lab-on-chip" describes microfluidic devices that integrate multiple laboratory functions - sample preparation, mixing, reaction, separation, and detection - onto a single chip the size of a credit card. This miniaturization reduces reagent consumption by 100-1000x, enables parallel processing, and brings laboratory capabilities to point-of-care settings.
10x Genomics' Chromium platform, powered by droplet microfluidics, has enabled researchers to map the Human Cell Atlas - cataloging every cell type in the human body. This foundational technology generated over $600M in revenue in 2023 alone.[2]
At the microscale, fluid behavior is fundamentally different from everyday experience. The Reynolds number (Re) - which compares inertial to viscous forces - determines flow characteristics. In microchannels, Re is typically less than 1, meaning viscous forces dominate completely.
Parallel fluid layers flow without mixing - diffusion is the only mechanism for molecular exchange
Manufacturing microfluidic devices requires precision techniques to create channels with dimensions measured in micrometers. The choice of fabrication method depends on material requirements, channel resolution, production volume, and cost constraints.
The most common prototyping method uses polydimethylsiloxane (PDMS), a transparent, biocompatible silicone rubber. The process involves creating a master mold via photolithography, then casting PDMS against this mold.
CAD design of channel geometry using software like AutoCAD or L-Edit
Print design onto photomask (chrome on glass or film)
Pattern SU-8 photoresist on silicon wafer using UV lithography
Pour liquid PDMS, degas, cure at 65C for 2 hours
Plasma treat and bond PDMS to glass slide or another PDMS layer
| Method | Materials | Resolution | Throughput | Best For |
|---|---|---|---|---|
| Soft Lithography | PDMS | 1-10 um | Low-Medium | Prototyping, research |
| 3D Printing (SLA) | Resins | 25-100 um | Medium | Rapid prototyping |
| 3D Printing (2PP) | Photoresins | 0.1-1 um | Low | High-resolution features |
| Injection Molding | COC, COP, PMMA | 1-50 um | Very High | Mass production |
| Hot Embossing | Thermoplastics | 1-50 um | High | Medium-volume production |
| Glass Etching | Glass, Fused Silica | 1-100 um | Low | Chemical resistance, optical |
| Laser Ablation | Various | 10-100 um | Medium | Rapid iteration |
Stereolithography (SLA) and two-photon polymerization (2PP) are transforming microfluidic prototyping. Modern SLA printers achieve 25-50 um resolution at costs under $500, enabling desktop microfluidic fabrication. Two-photon systems from companies like Nanoscribe achieve sub-micron resolution for complex 3D microstructures.
Microfluidics enables applications across diagnostics, drug discovery, and fundamental research by providing precise fluid control at scales matching cells and molecules.
Microfluidic devices recreate organ physiology with living cells. Continuous media flow mimics blood circulation while mechanical stretching simulates breathing or heartbeat. Enables human-relevant drug testing without animal models.
Lateral flow assays (like COVID rapid tests) and more complex microfluidic chips enable diagnosis at the bedside or in the field. Integrates sample processing, amplification, and detection into portable devices.
Microfluidic arrays test thousands of drug candidates simultaneously using nanoliter volumes. Reduces reagent costs by 1000x while increasing throughput. Standard in pharmaceutical lead optimization.
Droplet microfluidics isolates individual cells for sequencing their RNA or DNA. Reveals cellular heterogeneity hidden in bulk measurements. Transforming cancer research, immunology, and developmental biology.
Continuous flow microreactors provide precise temperature control and mixing for chemical synthesis. Enables reactions impossible in batch, including handling dangerous intermediates safely.
Microfluidic devices culture cells in controlled microenvironments and sort them based on size, deformability, or markers. Essential for stem cell research and cell therapy manufacturing.
Droplet microfluidics generates discrete water-in-oil droplets that serve as isolated micro-reactors. Each droplet can contain individual cells, reagents, or compounds, enabling millions of parallel experiments at unprecedented throughput.
Water droplets in oil carrier - each droplet is an isolated reaction chamber
Lab-on-chip (LOC) devices integrate complete laboratory workflows onto a single microfluidic chip. By miniaturizing sample preparation, reaction, separation, and detection, LOC systems bring laboratory capabilities to resource-limited settings and enable point-of-care diagnostics.
| System | Company | Application | Key Feature |
|---|---|---|---|
| Chromium | 10x Genomics | Single-cell sequencing | 10,000+ cells per run |
| Biomark HD | Standard BioTools | Gene expression | 9,216 reactions per chip |
| GeneXpert | Cepheid | Molecular diagnostics | Sample-to-answer in 45 min |
| FilmArray | BioFire/bioMerieux | Syndromic panels | 20+ pathogens in 1 hour |
| OrganoPlate | Mimetas | Organ-on-chip | 96 tissue models per plate |
Abbott's ID NOW platform used microfluidic isothermal amplification to deliver COVID-19 results in just 5 minutes. The compact, portable device enabled molecular-quality testing in pharmacies, airports, and physician offices - democratizing access to accurate diagnostics during the pandemic.
10x Genomics' Chromium platform, built on droplet microfluidics, has enabled researchers to profile gene expression in individual cells at unprecedented scale. This technology powered the Human Cell Atlas project and transformed our understanding of cellular heterogeneity in cancer, enabling personalized medicine approaches.
Emulate collaborated with the FDA to validate their Liver-Chip for predicting drug-induced liver injury (DILI). The microfluidic organ-chip correctly identified hepatotoxic drugs that had been missed by animal testing, demonstrating superior human relevance. This led to FDA acceptance of organ-chip data in regulatory submissions.
Microfluidic devices become truly powerful when integrated with advanced sensing technologies. These integrations enable real-time monitoring, automated decision-making, and quantitative readouts.
Fluorescence microscopy, absorbance spectroscopy, and surface plasmon resonance integrated on-chip. Enables real-time visualization of cell behavior and molecular binding events.
Integrated electrodes measure pH, oxygen, glucose, and biomarkers in real-time. Essential for monitoring cell metabolism and environmental conditions in organ-on-chip devices.
Direct coupling of microfluidics to mass spectrometry enables label-free identification of metabolites, proteins, and drugs. Ionization interfaces like ESI connect microchips to MS instruments.
Measure cell barrier integrity, proliferation, and migration non-invasively using electrical impedance. Standard for monitoring tissue-tissue interfaces in organ-on-chip models.
The microfluidics industry spans from component suppliers to integrated platform providers, with applications across diagnostics, research, and drug discovery.
Transitioning microfluidic technology from research prototypes to commercial products presents significant engineering, manufacturing, and regulatory challenges.
Moving from PDMS prototypes to injection-molded thermoplastics (COC, COP, PMMA) requires redesigning channels and bonding processes while maintaining performance.
Maintaining consistent surface properties across production batches is critical. Surface treatments, coatings, and functionalization must be reproducible at scale.
Connecting microfluidic chips to external equipment (pumps, reservoirs, instruments) requires standardized, leak-free interfaces that are user-friendly.
Medical device microfluidics must meet FDA 510(k) or CE marking requirements. Design controls, risk management, and quality systems add complexity and cost.
Combining microfluidics with sensors, electronics, and reagent storage into a manufacturable product requires multidisciplinary engineering expertise.
Tooling costs for injection molding can exceed $50,000 per design. Achieving cost-effective unit economics requires high volumes or premium pricing strategies.
Experience virtual microfluidic experiments in our interactive lab
Lung-on-Chip Body-on-Chip Organ-on-Chip All Simulations